Cambridge Investment Research Advisors’s Vanguard S&P Small-Cap 600 Growth ETF VIOG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.09M Sell
20,115
-210
-1% -$29.2K 0.01% 1358
2026
Q1
$2.53M Buy
20,325
+5,175
+34% +$660K 0.01% 1423
2025
Q4
$1.84M Buy
15,150
+19
+0.1% +$2.31K ﹤0.01% 1606
2025
Q3
$1.84M Sell
15,131
-827
-5% -$98.1K 0.01% 1563
2025
Q2
$1.83M Sell
15,958
-124
-0.8% -$13.3K 0.01% 1495
2025
Q1
$1.72M Sell
16,082
-612
-4% -$70.4K 0.01% 1453
2024
Q4
$1.94M Buy
16,694
+1,124
+7% +$137K 0.01% 1378
2024
Q3
$1.86M Buy
15,570
+564
+4% +$65.3K 0.01% 1404
2024
Q2
$1.65M Buy
15,006
+108
+0.7% +$11.9K 0.01% 1425
2024
Q1
$1.68M Buy
14,898
+1,245
+9% +$134K 0.01% 1383
2023
Q4
$1.47M Buy
13,653
+2,187
+19% +$211K 0.01% 1400
2023
Q3
$1.08M Buy
11,466
+69
+0.6% +$6.85K 0.01% 1526
2023
Q2
$1.13M Buy
11,397
+81
+0.7% +$7.63K 0.01% 1520
2023
Q1
$1.07M Buy
11,316
+1,150
+11% +$112K 0.01% 1529
2022
Q4
$947K Sell
10,166
-354
-3% -$33.5K ﹤0.01% 1543
2022
Q3
$921K Sell
10,520
-546
-5% -$52.8K 0.01% 1534
2022
Q2
$1M Sell
11,066
-4,424
-29% -$432K 0.01% 1485
2022
Q1
$1.67M Buy
15,490
+1,976
+15% +$215K 0.01% 1248
2021
Q4
$1.62M Buy
13,514
+986
+8% +$116K 0.01% 1270
2021
Q3
$1.41M Sell
12,528
-518
-4% -$58.9K 0.01% 1299
2021
Q2
$1.49M Buy
13,046
+258
+2% +$29K 0.01% 1277
2021
Q1
$1.41M Buy
12,788
+618
+5% +$67.7K 0.01% 1210
2020
Q4
$1.2M Sell
12,170
-1,784
-13% -$157K 0.01% 1192
2020
Q3
$1.06M Sell
13,954
-2,404
-15% -$185K 0.01% 1159
2020
Q2
$1.2M Buy
16,358
+1,336
+9% +$89.6K 0.01% 1021
2020
Q1
$889K Sell
15,022
-3,972
-21% -$301K 0.01% 1030
2019
Q4
$1.57M Sell
18,994
-2,490
-12% -$197K 0.01% 906
2019
Q3
$1.65M Sell
21,484
-19,284
-47% -$1.5M 0.01% 832
2019
Q2
$3.19M Sell
40,768
-2,670
-6% -$206K 0.03% 553
2019
Q1
$3.33M Buy
43,438
+2,668
+7% +$203K 0.03% 518
2018
Q4
$2.82M Buy
40,770
+2,010
+5% +$154K 0.03% 514
2018
Q3
$3.36M Buy
38,760
+5,816
+18% +$502K 0.03% 490
2018
Q2
$2.67M Buy
32,944
+6,258
+23% +$493K 0.03% 548
2018
Q1
$1.99M Buy
26,686
+14,798
+124% +$1.11M 0.02% 629
2017
Q4
$867K Buy
11,888
+4,246
+56% +$304K 0.01% 976
2017
Q3
$538K Buy
7,642
+558
+8% +$37.3K 0.01% 1221
2017
Q2
$474K Buy
7,084
+440
+7% +$29K 0.01% 1238
2017
Q1
$436K Buy
6,644
+1,322
+25% +$85.8K 0.01% 1145
2016
Q4
$342K Buy
5,322
+1,354
+34% +$81.8K 0.01% 1207
2016
Q3
$234K Sell
3,968
-564
-12% -$32.6K ﹤0.01% 1450
2016
Q2
$248K Buy
4,532
+32
+0.7% +$1.72K 0.01% 1273
2016
Q1
$240K Sell
4,500
-750
-14% -$37.4K 0.01% 1298
2015
Q4
$280K Buy
5,250
+784
+18% +$42.5K 0.01% 1157
2015
Q3
$230K Buy
4,466
+282
+7% +$15.5K 0.01% 1177
2015
Q2
$236K Buy
4,184
+536
+15% +$30K 0.01% 1182
2015
Q1
$204K Buy
+3,648
New +$195K 0.01% 1245

Other funds holding VIOG

Cambridge Investment Research Advisors's VIOG Position: Q2 2026 in Review

Cambridge Investment Research Advisors reduced its Vanguard S&P Small-Cap 600 Growth ETF (VIOG) stake by 1% in Q2 2026, selling an estimated $29.2K and leaving 20,115 shares worth $3.09M. The position accounts for 0.01% of the portfolio, ranked #1358.

Cambridge Investment Research Advisors first reported a position in VIOG in Q1 2015 and has held it in 46 quarters since. The position peaked at $3.36M in Q3 2018. 70 funds tracked by Wall St. Rank hold VIOG as of Q2 2026.

  • Cambridge Investment Research Advisors held 20,115 shares of Vanguard S&P Small-Cap 600 Growth ETF worth $3.09M as of Q2 2026.
  • Cambridge Investment Research Advisors sold 210 Vanguard S&P Small-Cap 600 Growth ETF shares in Q2 2026, an estimated $29.2K.
  • Vanguard S&P Small-Cap 600 Growth ETF made up 0.01% of Cambridge Investment Research Advisors's portfolio in Q2 2026, its #1358 holding.
  • Cambridge Investment Research Advisors first reported a position in Vanguard S&P Small-Cap 600 Growth ETF in Q1 2015 and has held it in 46 quarters since.
  • Cambridge Investment Research Advisors's Vanguard S&P Small-Cap 600 Growth ETF position peaked at $3.36M in Q3 2018.
  • 70 funds tracked by Wall St. Rank held Vanguard S&P Small-Cap 600 Growth ETF as of Q2 2026.

Based on Cambridge Investment Research Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.